(PharmaNewsWire.Com, January 20, 2018 ) The Europe Superdisintegrants Market was worth USD 71.5 million in 2016 and estimated to be growing at a CAGR of 7.2%, to reach USD 101.3 million by 2021. Increasing healthcare expenditure and healthcare awareness among individuals has accounted for the growth of this market.
Excipients are the substance that is fabricated alongside medicating ingredient for the purpose of long term stabilization, bulking up solid contents etc. Superdisintegrants are one of the types of excipients that help in fragmenting and dissolving the tablet when contacted with water. It provides advantages like faster medicating action increased effectiveness.
The factors accountable for the growth of market are growing generic drugs market, growing population of geriatric and paediatric patients and development of new superdisintegrants in pharmaceutical industry. However, the markets growth is slowed by the declining financial support for R&D fields. Although synthetic superdisintegrants have been the standard for many decades now, greater research into natural superdisintegrants will provide a motivation for the future growth of the market.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
